IL6 and diabetes mellitus: Studies have reported that diabetes-induced gliosis eventually leads to the production and release by MGCs of inflammatory molecules such as interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and chemokine ligand-2 (CCL2) [6,7].